Cargando…

Adherence to inhaled corticosteroids in relation to quality of life and symptoms of anxiety and depression in asthma

BACKGROUND: Poor asthma control, often caused by non-adherence with controller medication, is a well-known risk factor for impaired quality of life (QoL) and major mood disorders (MMD). Previous studies have shown a relationship between non-adherence, lower QoL, and MMD across chronic diseases, but...

Descripción completa

Detalles Bibliográficos
Autores principales: Renzi-Lomholt, Martino, Håkansson, Kjell Erik Julius, Suppli Ulrik, Charlotte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704108/
https://www.ncbi.nlm.nih.gov/pubmed/36452910
http://dx.doi.org/10.1080/20018525.2022.2149920
_version_ 1784839991731421184
author Renzi-Lomholt, Martino
Håkansson, Kjell Erik Julius
Suppli Ulrik, Charlotte
author_facet Renzi-Lomholt, Martino
Håkansson, Kjell Erik Julius
Suppli Ulrik, Charlotte
author_sort Renzi-Lomholt, Martino
collection PubMed
description BACKGROUND: Poor asthma control, often caused by non-adherence with controller medication, is a well-known risk factor for impaired quality of life (QoL) and major mood disorders (MMD). Previous studies have shown a relationship between non-adherence, lower QoL, and MMD across chronic diseases, but the relationship remains uncertain in asthma. METHODS: All asthma patients followed at the respiratory outpatient clinic at Copenhagen University Hospital – Hvidovre were invited to fill-in the Hospital Anxiety and Depression Scale (HADS) and the Mini Asthma Quality of Life Questionnaire (miniAQLQ). Medication Possession Ratio (MPR) was calculated using pharmacy redemption data. Relationships between questionnaire scores, inhaled corticosteroid MPR and use of rescue medication were investigated using Pearson correlation and multivariable linear regression adjusted for age, sex, FEV(1), and GINA Step. Data from scheduled visits were collected from patients’ medical records. RESULTS: A total of 308 patients (73% females, median age 51 years (interquartile range (IQR) 37, 62)) completed the questionnaires and had 1-year medication data available. Median adherence to inhaled corticosteroids (ICS) was 57% (35%, 75%) with 18% of patients having adherence above 80%. Of the participating patients, 14% and 27% reported depressive and anxiety-related symptoms, respectively, and 72% reported impaired QoL. In correlation analyses, ICS adherence was not significantly associated with either prevalence of MMD symptoms or impaired QoL in asthma patients. However, a strong correlation was found between ACQ-6 and both MMD symptoms and impaired QoL, as well as between rescue medication use and impaired QoL. In adjusted analysis, however, the latter correlation was no longer statistically significant. CONCLUSION: Our results suggest that ICS adherence is not directly correlated with either impaired quality of life or major mood disorder symptoms in asthma patients. Self-reported asthma control, on the other hand, is strongly correlated with both QoL and MMD.
format Online
Article
Text
id pubmed-9704108
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-97041082022-11-29 Adherence to inhaled corticosteroids in relation to quality of life and symptoms of anxiety and depression in asthma Renzi-Lomholt, Martino Håkansson, Kjell Erik Julius Suppli Ulrik, Charlotte Eur Clin Respir J Research Article BACKGROUND: Poor asthma control, often caused by non-adherence with controller medication, is a well-known risk factor for impaired quality of life (QoL) and major mood disorders (MMD). Previous studies have shown a relationship between non-adherence, lower QoL, and MMD across chronic diseases, but the relationship remains uncertain in asthma. METHODS: All asthma patients followed at the respiratory outpatient clinic at Copenhagen University Hospital – Hvidovre were invited to fill-in the Hospital Anxiety and Depression Scale (HADS) and the Mini Asthma Quality of Life Questionnaire (miniAQLQ). Medication Possession Ratio (MPR) was calculated using pharmacy redemption data. Relationships between questionnaire scores, inhaled corticosteroid MPR and use of rescue medication were investigated using Pearson correlation and multivariable linear regression adjusted for age, sex, FEV(1), and GINA Step. Data from scheduled visits were collected from patients’ medical records. RESULTS: A total of 308 patients (73% females, median age 51 years (interquartile range (IQR) 37, 62)) completed the questionnaires and had 1-year medication data available. Median adherence to inhaled corticosteroids (ICS) was 57% (35%, 75%) with 18% of patients having adherence above 80%. Of the participating patients, 14% and 27% reported depressive and anxiety-related symptoms, respectively, and 72% reported impaired QoL. In correlation analyses, ICS adherence was not significantly associated with either prevalence of MMD symptoms or impaired QoL in asthma patients. However, a strong correlation was found between ACQ-6 and both MMD symptoms and impaired QoL, as well as between rescue medication use and impaired QoL. In adjusted analysis, however, the latter correlation was no longer statistically significant. CONCLUSION: Our results suggest that ICS adherence is not directly correlated with either impaired quality of life or major mood disorder symptoms in asthma patients. Self-reported asthma control, on the other hand, is strongly correlated with both QoL and MMD. Taylor & Francis 2022-11-24 /pmc/articles/PMC9704108/ /pubmed/36452910 http://dx.doi.org/10.1080/20018525.2022.2149920 Text en © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Renzi-Lomholt, Martino
Håkansson, Kjell Erik Julius
Suppli Ulrik, Charlotte
Adherence to inhaled corticosteroids in relation to quality of life and symptoms of anxiety and depression in asthma
title Adherence to inhaled corticosteroids in relation to quality of life and symptoms of anxiety and depression in asthma
title_full Adherence to inhaled corticosteroids in relation to quality of life and symptoms of anxiety and depression in asthma
title_fullStr Adherence to inhaled corticosteroids in relation to quality of life and symptoms of anxiety and depression in asthma
title_full_unstemmed Adherence to inhaled corticosteroids in relation to quality of life and symptoms of anxiety and depression in asthma
title_short Adherence to inhaled corticosteroids in relation to quality of life and symptoms of anxiety and depression in asthma
title_sort adherence to inhaled corticosteroids in relation to quality of life and symptoms of anxiety and depression in asthma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704108/
https://www.ncbi.nlm.nih.gov/pubmed/36452910
http://dx.doi.org/10.1080/20018525.2022.2149920
work_keys_str_mv AT renzilomholtmartino adherencetoinhaledcorticosteroidsinrelationtoqualityoflifeandsymptomsofanxietyanddepressioninasthma
AT hakanssonkjellerikjulius adherencetoinhaledcorticosteroidsinrelationtoqualityoflifeandsymptomsofanxietyanddepressioninasthma
AT suppliulrikcharlotte adherencetoinhaledcorticosteroidsinrelationtoqualityoflifeandsymptomsofanxietyanddepressioninasthma